S
Stacy Loeb
Researcher at New York University
Publications - 462
Citations - 14637
Stacy Loeb is an academic researcher from New York University. The author has contributed to research in topics: Prostate cancer & Prostate-specific antigen. The author has an hindex of 58, co-authored 413 publications receiving 12226 citations. Previous affiliations of Stacy Loeb include National Institutes of Health & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Systematic review of complications of prostate biopsy.
Stacy Loeb,Annelies Vellekoop,Hashim U. Ahmed,James W.F. Catto,Mark Emberton,Robert K. Nam,Derek J. Rosario,Vincenzo Scattoni,Yair Lotan +8 more
TL;DR: Preparation for biopsy should include antimicrobial prophylaxis and pain management, and infectious complications are increasing over time and are the most common reason for hospitalization after biopsy.
Journal ArticleDOI
Overdiagnosis and Overtreatment of Prostate Cancer
Stacy Loeb,Marc A. Bjurlin,Joseph Nicholson,Teuvo L.J. Tammela,David F. Penson,H. Ballentine Carter,Peter R. Carroll,Ruth Etzioni +7 more
TL;DR: Empirical, clinical, and autopsy studies have been used to examine PCa overdiagnosis, with estimates ranging widely from 1.7% to 67%.
Journal ArticleDOI
Complications After Prostate Biopsy: Data From SEER-Medicare
TL;DR: Infectious complications after prostate biopsy have increased in recent years while the rate of serious noninfectious complications is relatively stable, and among men undergoing biopsy, later year, nonwhite race and higher comorbidity scores were significantly associated with an increased risk of infectious complications.
Journal ArticleDOI
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona,Alan W. Partin,Martin G. Sanda,John T. Wei,George G. Klee,Chris H. Bangma,Kevin M. Slawin,Leonard S. Marks,Stacy Loeb,Dennis L. Broyles,Sanghyuk S. Shin,Amabelle B. Cruz,Daniel W. Chan,Lori J. Sokoll,William L. Roberts,Ron H.N. van Schaik,Isaac A. Mizrahi +16 more
TL;DR: The prostate health index may be useful in prostate cancer screening to decrease unnecessary biopsy in men 50 years old or older with prostate specific antigen 2 to 10 ng/ml and negative digital rectal examination with minimal loss in sensitivity.
Journal ArticleDOI
Complications After Systematic, Random, and Image-guided Prostate Biopsy
Marco Borghesi,Hashim U. Ahmed,Robert K. Nam,Edward M. Schaeffer,Riccardo Schiavina,Samir S. Taneja,Wolfgang Weidner,Stacy Loeb +7 more
TL;DR: Complications after prostate biopsy are frequent but often self-limiting, and transperineal and in-bore MRI-targeted biopsy may reduce the risk of severe infectious complications.